News & Events
Read our recent press releases and follow Vascudyne’s newest advancements
June 07, 2022
Vascudyne Announces Presentation of First Clinical Results of TRUE AVC™ in Hemodialysis Access at the VASA Conference
Vascudyne is proud to announce the first clinical results of its hemodialysis access conduits at the Vascular Access Society of the Americas (VASA) conference in Charleston, South Carolina on June 10, 2022.
Monnie Wasse, MD, MPH, FASN, Professor of Medicine in the Division of Nephrology and the Department of Internal Medicine at Rush University Medical Center and Vascudyne’s medical advisor will present the “First in Human Evaluation of a Novel Biologic Regenerative Vascular Conduit for Hemodialysis Access”. The presentation will include 6-month clinical results and preliminary evidence of the safety and effectiveness of Vascudyne’s tissue technology as a conduit for hemodialysis vascular access.
Address
Social Media
These are investigational uses that have not been approved by any health authority. Safety and efficacy have not been established and there is no guarantee that pipeline products or investigational uses will receive approval from health authorities.
Copyright 2025 | Vascudyne, Inc.
